CARVEDILOL EFFECTS ON INSULIN RESISTANCE AS A FACTOR DEFINING CLINICAL EFFECTIVENESS IN METABOLIC SYNDROME
Autor: | V. E. Oleynikov, I. B. Matrosova, I. V. Eliseeva, Yu. A. Tomashevskaya |
---|---|
Jazyk: | ruština |
Rok vydání: | 2009 |
Předmět: | |
Zdroj: | Российский кардиологический журнал, Vol 0, Iss 2, Pp 59-64 (2009) |
Druh dokumentu: | article |
ISSN: | 1560-4071 2618-7620 |
Popis: | In 62 patients with Stage I-II arterial hypertension (AH) and metabolic syndrome (MS), clinical effectiveness and insulin resistance (IR) effects of a non-selective alpha-beta-adrenoblocker carvetrend were investigated, for 16-week carvetrend monotherapy, carvetrend combination with corinfar UNO, or their combination with formin and zorstat. Carvetrend, as monotherapy or combined with corinfar UNO, effectively reduced office and 24-hour monitoring blood pressure levels, regardless of the risk factor number. Carvetrend increased peripheral tissue insulin sensitivity, without affecting carbohydrate and lipid metabolism. |
Databáze: | Directory of Open Access Journals |
Externí odkaz: |